Cogent Biosciences (COGT) Research & Development (2017 - 2020)
Historic Research & Development for Cogent Biosciences (COGT) over the last 4 years, with Q4 2020 value amounting to $6.1 million.
- Cogent Biosciences' Research & Development fell 4100.83% to $6.1 million in Q4 2020 from the same period last year, while for Dec 2020 it was $25.7 million, marking a year-over-year decrease of 4111.51%. This contributed to the annual value of $25.7 million for FY2020, which is 4111.51% down from last year.
- Latest data reveals that Cogent Biosciences reported Research & Development of $6.1 million as of Q4 2020, which was down 4100.83% from $5.0 million recorded in Q3 2020.
- Cogent Biosciences' 5-year Research & Development high stood at $12.4 million for Q1 2019, and its period low was $5.0 million during Q3 2020.
- Over the past 4 years, Cogent Biosciences' median Research & Development value was $8.7 million (recorded in 2017), while the average stood at $8.6 million.
- Its Research & Development has fluctuated over the past 5 years, first surged by 5233.36% in 2019, then plummeted by 5169.07% in 2020.
- Quarter analysis of 4 years shows Cogent Biosciences' Research & Development stood at $7.6 million in 2017, then soared by 42.36% to $10.8 million in 2018, then decreased by 3.82% to $10.4 million in 2019, then tumbled by 41.01% to $6.1 million in 2020.
- Its last three reported values are $6.1 million in Q4 2020, $5.0 million for Q3 2020, and $5.1 million during Q2 2020.